Trial · NCT02431702
Adverse event totals18
The totals the trial posted for each group.
1 to 18 of 18
Download this page as JSON| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Part 1-Run-in: Oral Antipsychotics (OAP) | 0 | 273 |
| Total, all-cause mortality | Part 2-Paliperidone Palmitate (PP) | 1 | 78 |
| Total, all-cause mortality | Part 2-OAP | 0 | 157 |
| Total, all-cause mortality | Part 3-PP to PP (Extended Disease Progression [EDP] and Disease Modification) | 0 | 49 |
| Total, all-cause mortality | Part 3- OAP to PP (or Delayed-Start PP) (Disease Modification) | 0 | 57 |
| Total, all-cause mortality | Part 3-OAP to OAP (EDP and Disease Modification) | 0 | 63 |
| Total, other adverse events | Part 1-Run-in: Oral Antipsychotics (OAP) | 116 | 273 |
| Total, other adverse events | Part 2-Paliperidone Palmitate (PP) | 50 | 78 |
| Total, other adverse events | Part 2-OAP | 89 | 157 |
| Total, other adverse events | Part 3-PP to PP (Extended Disease Progression [EDP] and Disease Modification) | 18 | 49 |
| Total, other adverse events | Part 3- OAP to PP (or Delayed-Start PP) (Disease Modification) | 34 | 57 |
| Total, other adverse events | Part 3-OAP to OAP (EDP and Disease Modification) | 27 | 63 |
| Total, serious adverse events | Part 1-Run-in: Oral Antipsychotics (OAP) | 10 | 273 |
| Total, serious adverse events | Part 2-Paliperidone Palmitate (PP) | 10 | 78 |
| Total, serious adverse events | Part 2-OAP | 19 | 157 |
| Total, serious adverse events | Part 3-PP to PP (Extended Disease Progression [EDP] and Disease Modification) | 1 | 49 |
| Total, serious adverse events | Part 3- OAP to PP (or Delayed-Start PP) (Disease Modification) | 3 | 57 |
| Total, serious adverse events | Part 3-OAP to OAP (EDP and Disease Modification) | 8 | 63 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02431702/event-totals